Evarrest Market Report 2026

Evarrest Market Overview

• The Evarrest market growth in the historic period has been driven by high surgical bleeding complications, limitations of traditional suturing methods • Market expansion is supported by growth in complex surgical procedures, rising trauma incidence • Growth Driver: Growth Of Market Driven By Increase In Surgical Procedures • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Evarrest Market?

Evarrest is an FDA-approved fibrin sealant patch designed to control bleeding during surgeries, featuring a flexible composite patch coated with human fibrinogen and thrombin for rapid clot formation. It is especially useful in emergency situations, requiring no preparation and effectively stopping bleeding on the first attempt. The main types of indications in evarrest are surgical procedures and trauma cases. Surgical procedures are medical operations used to treat, diagnose, or prevent conditions, ranging from minor to complex interventions. These drugs can be made up of various formulations, including powder form and pre-mixed solution, and are distributed through hospitals, pharmacies, and online platforms.

What Is The Evarrest Market Growth Forecast?

The growth in the forecast period can be attributed to growth in complex surgical procedures, rising trauma incidence, expanding hospital infrastructure, increasing surgeon preference for sealant patches, technological advances in surgical biomaterials. Major trends in the forecast period include rising demand for rapid surgical hemostasis, increased use of ready-to-use hemostatic patches, growth in emergency and trauma surgeries, preference for no-preparation bleeding control solutions, expansion of advanced surgical care infrastructure.

Global Evarrest Market Segmentation

1) By Indication: Surgical Procedures, Trauma Cases 2) By Formulation: Powder Form, Pre-Mixed Solution 3) By Distribution Channel: Hospitals, Pharmacies, Online Platforms

What Are The Drivers Of The Evarrest Market?

An increase in the number of surgical procedures is expected to propel the growth of the evarrest market going forward. Surgical procedures refer to medical operations or interventions performed by a surgeon to treat, diagnose, or prevent a condition, injury, or disease. The number of surgical procedures is increasing due to the aging population and advancements in medical technology, which have made surgeries safer and more accessible. Evarrest is used in surgical procedures by applying its fibrin sealant patch to bleeding sites, where it promotes rapid clot formation to control bleeding effectively. For instance, in December 2023, according to the UK Health Security Agency, a UK-based government agency, coronary artery bypass graft surgeries increased in 2023 with 27,524 surgeries compared to previous years. Therefore, an increase in the number of surgical procedures is driving the growth of the evarrest industry. The growing adoption of personalized medicine is anticipated to drive the future growth of the evarrest market. Personalized medicines refer to treatments tailored to an individual's genetic makeup, lifestyle, and specific health conditions, aiming for more effective and precise care. The rising adoption of personalized medicine is driven by its ability to offer more effective, targeted treatments with fewer side effects. Personalized medicine for evarrest tailors its use based on individual patient factors, such as genetic traits or clotting disorders, to improve treatment effectiveness and safety. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based nonprofit organization, in 2023, the FDA approved 16 new personalized treatments for rare diseases, up from six in 2022. Therefore, the rising adoption of personalized medicines is driving the growth of the evarrest industry. The rising healthcare expenditure is anticipated to propel the growth of the evarrest market going forward. Healthcare expenditure refers to the total financial resources spent on medical services, preventive care, medications, and health-related activities to improve or maintain population health. Healthcare expenditure is growing due to aging populations requiring more medical care and advancements in technology that increase treatment costs. Healthcare expenditure drives the adoption of evarrest by increasing investment in advanced medical technologies that improve surgical outcomes and reduce complications. For instance, in December 2024, the Centers for Medicare & Medicaid Services (CMS), US-based a federal agency, reported that U.S. healthcare spending rose by 7.5% in 2023 to $4.9 trillion, up from a 4.6% increase in 2022. Therefore, the rising healthcare expenditure is driving the growth of the evarrest industry.

Key Players In The Global Evarrest Market

Major companies operating in the evarrest market are Johnson & Johnson

Regional Insights

North America was the largest region in the evarrest market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Evarrest Market?

The evarrest market consists of sales of products including the evarrest fibrin sealant patch, surgical powder absorbable hemostat, surgiflo hemostatic matrix, harmonic devices, and endopath products. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Evarrest Market Report 2026?

The evarrest market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the evarrest industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.